Sebastián A. García
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sebastián A. García has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Jürgen Weitz
Department of Gastrointestinal, Thoracic and Vascular Surgery, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany
5 shared publications- Sebastian Schölch
JCCU Translational Surgical Oncology (A430), German Cancer Research Center (DKFZ), Heidelberg, Germany; DKFZ-Hector Cancer Institute, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Department of Surgery, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
5 shared publications Alexander M. Betzler
Department of Gastrointestinal, Thoracic and Vascular Surgery, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden
3 shared publicationsNuh N. Rahbari
Department of Gastrointestinal, Thoracic and Vascular Surgery, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Fetscherstr. 74, 01307 Dresden, Germany
3 shared publicationsUlrich Bork
Department of Gastrointestinal, Thoracic and Vascular Surgery, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Fetscherstr. 74, 01307 Dresden, Germany
3 shared publicationsAnka Swiersy
Department of Gastrointestinal, Thoracic and Vascular Surgery, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Fetscherstr. 74, 01307 Dresden, Germany
2 shared publications
Latest Publications
- 7 October 2017
- Published by Springer Nature
- Vol. 1692, 213-219
Circulating Tumor Cells
In most solid tumors, it is distant metastases rather than the primary tumor which limit the prognosis. Distant metastases are caused by circulating tumor cells (CTCs) which actively invade the blood stream, attach to the endothelium in the target organ, invade the surrounding parenchyma, and form new tumors. Among many other capabilities such as migration or immune escape, CTCs require tumor-forming capacities and can therefore be considered stem cell-like cells. This chapter describes the enrichment and isolation of live CTCs from clinical blood samples for molecular characterization and other downstream applications.
- 7 October 2017
- Published by Springer Nature
- Vol. 1692, 213-219
Circulating Tumor Cells
In most solid tumors, it is distant metastases rather than the primary tumor which limit the prognosis. Distant metastases are caused by circulating tumor cells (CTCs) which actively invade the blood stream, attach to the endothelium in the target organ, invade the surrounding parenchyma, and form new tumors. Among many other capabilities such as migration or immune escape, CTCs require tumor-forming capacities and can therefore be considered stem cell-like cells. This chapter describes the enrichment and isolation of live CTCs from clinical blood samples for molecular characterization and other downstream applications.
- 18 July 2017
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 125,p. e55357
Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer
We describe the establishment of orthotopic colorectal tumors via injection of tumor cells or organoids into the cecum of mice and the...
- 18 July 2017
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 125,p. e55357
Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer
We describe the establishment of orthotopic colorectal tumors via injection of tumor cells or organoids into the cecum of mice and the...
- Open Access
- 5 October 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (51) , 84258-84270
LDB1overexpression is a negative prognostic factor in colorectal cancer
LDB1 overexpression is a negative prognostic factor in colorectal cancer
- 5 October 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (51) , 84258-84270
Open AccessLDB1overexpression is a negative prognostic factor in colorectal cancer
LDB1 overexpression is a negative prognostic factor in colorectal cancer
- Open Access
- 25 March 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (19) , 27232-27242
Circulating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer
Circulating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer Circulating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer
- 25 March 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (19) , 27232-27242
Open AccessCirculating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer
Circulating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer Circulating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer
- Open Access
- 13 March 2014
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 74 (6) , 1694-1704
Immune Escape and Survival Mechanisms in Circulating Tumor Cells of Colorectal Cancer
The prognosis of colorectal cancer is closely linked to the occurrence of distant metastases. Systemic dissemination is most likely caused by circulating tumor cells (CTC). Despite the fundamental role of CTC within the metastatic cascade, technical obstacles have so far prevented detailed genomic and, in particular, phenotypic analyses of CTC, which may provide molecular targets to delay or prevent distant metastases. We show here a detailed genomic analysis of single colorectal cancer–derived CTC by array comparative genomic hybridization (aCGH), mutational profiling, and microsatellite instability (MSI) analysis. Furthermore, we report the first gene expression analysis of manually selected colorectal cancer–derived CTC by quantitative real-time PCR (qRT-PCR) to investigate transcriptional changes, enabling CTC to survive in circulation and form distant metastases. aCGH confirmed the tumor cell identity of CellSearch-isolated colorectal cancer–derived CTC. Mutational and MSI analyses revealed mutational profiles of CTC to be similar, but not identical to the corresponding tumor tissue. Several CTC exhibited mutations in key genes such as KRAS or TP53 that could not be detected in the tumor. Gene expression analyses revealed both a pronounced upregulation of CD47 as a potential immune-escape mechanism and a significant downregulation of several other pathways, suggesting a dormant state of viable CTC. Our results suggest mutational heterogeneity between tumor tissue and CTC that should be considered in future trials on targeted therapy and monitoring of response. The finding of upregulated immune-escape pathways, which may be responsible for survival of CTC in circulation, could provide a promising target to disrupt the metastatic cascade in colorectal cancer. Cancer Res; 74(6); 1694–704. ©2014 AACR.
- 13 March 2014
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 74 (6) , 1694-1704
Open AccessImmune Escape and Survival Mechanisms in Circulating Tumor Cells of Colorectal Cancer
The prognosis of colorectal cancer is closely linked to the occurrence of distant metastases. Systemic dissemination is most likely caused by circulating tumor cells (CTC). Despite the fundamental role of CTC within the metastatic cascade, technical obstacles have so far prevented detailed genomic and, in particular, phenotypic analyses of CTC, which may provide molecular targets to delay or prevent distant metastases. We show here a detailed genomic analysis of single colorectal cancer–derived CTC by array comparative genomic hybridization (aCGH), mutational profiling, and microsatellite instability (MSI) analysis. Furthermore, we report the first gene expression analysis of manually selected colorectal cancer–derived CTC by quantitative real-time PCR (qRT-PCR) to investigate transcriptional changes, enabling CTC to survive in circulation and form distant metastases. aCGH confirmed the tumor cell identity of CellSearch-isolated colorectal cancer–derived CTC. Mutational and MSI analyses revealed mutational profiles of CTC to be similar, but not identical to the corresponding tumor tissue. Several CTC exhibited mutations in key genes such as KRAS or TP53 that could not be detected in the tumor. Gene expression analyses revealed both a pronounced upregulation of CD47 as a potential immune-escape mechanism and a significant downregulation of several other pathways, suggesting a dormant state of viable CTC. Our results suggest mutational heterogeneity between tumor tissue and CTC that should be considered in future trials on targeted therapy and monitoring of response. The finding of upregulated immune-escape pathways, which may be responsible for survival of CTC in circulation, could provide a promising target to disrupt the metastatic cascade in colorectal cancer. Cancer Res; 74(6); 1694–704. ©2014 AACR.